Development and characterization of SARS-CoV-2 variant-neutralizing monoclonal antibodies.
Qiu H, Yuan XY, Cabral T, Manguiat K, Robinson A, Wood H, Grant C, McQueen P, Westmacott G, Beniac DR, Lin L, Carpenter M, Kobasa D, Gräfenhan T.
Qiu H, et al.
Antiviral Res. 2021 Dec;196:105206. doi: 10.1016/j.antiviral.2021.105206. Epub 2021 Nov 8.
Antiviral Res. 2021.
PMID: 34762975
Free PMC article.